Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug 30;11(1):2397174.
doi: 10.1080/20018525.2024.2397174. eCollection 2024.

Comorbid allergy and rhinitis and patient-related outcomes in asthma and COPD: a cross-sectional study

Affiliations

Comorbid allergy and rhinitis and patient-related outcomes in asthma and COPD: a cross-sectional study

Zainab Al-Hadrawi et al. Eur Clin Respir J. .

Abstract

Introduction: The study aimed to compare prevalence of comorbid allergic manifestations and rhinitis, allergy testing and associations with patient-related outcomes in patients with asthma and COPD.

Methods: Cross-sectional study of randomly selected Swedish patients with a doctor's diagnosis of asthma (n = 1291) or COPD (n = 1329). Self-completion questionnaires from 2014 provided data on demographics, rhinitis, allergic symptoms at exposure to pollen or furry pets, exacerbations, self-assessed severity of disease and scores from the Asthma Control Test (ACT) and the COPD Assessment Test (CAT), and records were reviewed for allergy tests.

Results: Allergic manifestations were more common in asthma (75%) compared with COPD (38%). Rhinitis was reported in 70% of asthma and 58% of COPD patients. Allergy tests had been performed during the previous decade in 28% of patients with asthma and in 8% of patients with COPD.In patients with asthma; comorbid allergy and rhinitis were both independently associated with increased risk for poor asthma symptom control (ACT < 20) (OR [95% CI] 1.41 [1.05 to 1.87] and 2.13 [1.60 to 2.83]), exacerbations (1.58 [1.15 to 2.17] and 1.38 [1.02 to 1.86]), and self-assessed moderate/severe disease (1.64 [1.22 to 2.18] and 1.75 [1.33 to 2.30]). In patients with COPD, comorbid allergy and rhinitis were both independently associated with increased risk for low health status (CAT ≥ 10) (OR [95% CI] 1.46 [1.20 to 1.95] and 2.59 [1.97 to 3.41]) respectively, with exacerbations during the previous six months (1.91 [1.49 to 2.45] and 1.57 [1.23 to 2.01]), and with self-assessed moderate/severe disease (1.70 [1.31 to 2.22] and 2.13 [1.66 to 2.74]).

Conclusion: Allergic manifestations and rhinitis are more common in asthma than COPD but associated with worse outcomes in both diseases. This highlights the importance of examining and treating comorbid allergy and rhinitis, not only in asthma but also in COPD.

Keywords: Asthma; allergy; assessment test; asthma control test; chronic bstructive pulmonary disease; exacerbations; rhinitis; self-assessed severity of disease.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported by the author(s).

Figures

Flow chart of selection procedure and data collection. Abbreviations: COPD = chronic obstructive pulmonary disease, N = numbers.
Figure 1.
Flow chart.
Proportion of patients with comorbid allergy and rhinitis in asthma and COPD. Abbreviations: COPD = chronic obstructive pulmonary disease.
Figure 2.
Prevalence of allergy and rhinitis in asthma and COPD.
Results from multivariable logistic regression with adjustment for sex, age, smoking habits, body mass index and educational level, estimates expressed as odds ratios with 95% confidence intervals. Abbreviations: COPD = chronic obstructive pulmonary disease.
Figure 3.
Associations of allergy and rhinitis with patient-related outcomes.

References

    1. GINA Report. 2024. [cited 2024 May 10]. Available from: https://ginasthma.org
    1. GOLD report. 2024. [cited 2024 May 10]. Available from: https://goldcopd.org
    1. Bachert C, van Cauwenberge P, Olbrecht J, et al. Prevalence, classification and perception of allergic and nonallergic rhinitis in Belgium. Allergy. 2006;61(6):693–7. doi: 10.1111/j.1398-9995.2006.01054.x - DOI - PubMed
    1. Backer V, Klein DK, Bodtger U, et al. Clinical characteristics of the BREATHE cohort – a real-life study on patients with asthma and COPD. Eur Clin Respir J. 2020;7(1):1736934. doi: 10.1080/20018525.2020.1736934 - DOI - PMC - PubMed
    1. Magnan A, Meunier JP, Saugnac C, et al. Original article: frequency and impact of allergic rhinitis in asthma patients in everyday general medical practice: a French observational cross-sectional study. Allergy. 2008. Mar;63(3):292–298. doi: 10.1111/j.1398-9995.2007.01584.x - DOI - PubMed

LinkOut - more resources